These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less. Schiffer JM, McNeil MM, Quinn CP. Expert Rev Vaccines; 2016 Sep; 15(9):1151-62. PubMed ID: 26942655 [Abstract] [Full Text] [Related]
13. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG. Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP. J Immunol Methods; 2012 Feb 28; 376(1-2):97-107. PubMed ID: 22197974 [Abstract] [Full Text] [Related]
17. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers. Rynkiewicz D, Rathkopf M, Sim I, Waytes AT, Hopkins RJ, Giri L, DeMuria D, Ransom J, Quinn J, Nabors GS, Nielsen CJ. Vaccine; 2011 Aug 26; 29(37):6313-20. PubMed ID: 21624418 [Abstract] [Full Text] [Related]
18. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Pondo T, Rose CE, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM. Vaccine; 2014 Jun 12; 32(28):3548-54. PubMed ID: 24768633 [Abstract] [Full Text] [Related]